AMGEN INC. v. PRINSTON PHARMACEUTICAL INC. > Summary
Court Case Number 3:18-cv-11216
Filing Date Jun 28, 2018
Termination Date Mar 24, 2021
Court New Jersey District Court
Status Dismissed - Settled
Defendant
Plaintiff Attorneys
19Amgen
Attorney Name: Charles H. Chevalier
Gibbons P.C.
Amgen
Attorney Name: Christine A. Gaddis
Gibbons P.C.
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: George F. Pappas
Covington & Burling LLP
Celgene
Attorney Name: Christopher N. Sipes
Covington & Burling LLP
Celgene
Attorney Name: Michael N. Kennedy
Covington & Burling LLP
Celgene
Attorney Name: Alexa R. Hansen
Covington & Burling LLP
Amgen
Attorney Name: Dennis J. Smith
Amgen
Amgen
Attorney Name: Eric M. Agovino
Amgen
Amgen
Attorney Name: Christina N. Gifford
Amgen
Amgen
Attorney Name: Wendy A. Whiteford
Amgen
Amgen
Attorney Name: Gregory D. Bonifield
Amgen
Attorney Name: David Leigh Moses
Attorney Name: Christina N. Gifford
Attorney Name: Sarah A. Geers
Attorney Name: Charles M. Lizza
Attorney Name: Steven J. Horowitz
Defendant Attorneys
4Prinston Pharmaceutical Inc.
Attorney Name: Hua Wang
Budd Larner
Prinston Pharmaceutical Inc.
Attorney Name: Louis H. Weinstein
Windels Marx Lane & Mittendorf, LLP
Attorney Name: Louis H. Weinstein
Attorney Name: Hua Wang
Cause
15:1126 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10092541 | Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast | Oct 9, 2018 |
07427638 | (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof | Sep 23, 2008 |